Women Who Carry Small-For-Gestational-Age Babies In First Pregnancy At Increased Risk For Recurrence In Second Pregnancy
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in San Francisco, researchers will report findings that suggest women whose babies are small-for-gestational-age (SGA) in their first pregnancy have a strongly increased risk for SGA in a second pregnancy.
The aim of this study was to assess and describe in detail the incidence of SGA infants and the SGA recurrence rate in general. Additionally, it sought to assess the incidence and recurrence rate of SGA in women with and without a hypertensive disorder in their first pregnancy.
Infants who are small for gestational age (birth weight below the fifth percentile) are a heterogeneous group comprised of infants that have failed to achieve their growth potential (fetal growth restriction; FGR) and infants who are constitutionally small. SGA infants are at increased risk for perinatal mortality and adverse perinatal and health outcomes later in life.
“The main strength of this study was the size and composition of the cohort,” said B J Voskamp, MD. “Data were derived from a large, well-maintained, population-based national perinatal registry.”
The study was performed in a prospective nationwide cohort with the use of the Netherlands Perinatal Registry (PRN). The PRN consists of population-based data that includes information on pregnancy and delivery of 96 percent of pregnancies in the Netherlands. From this, they studied a cohort of women who delivered two subsequent singleton pregnancies (first and second deliveries) in the Netherlands from Jan. 1, 1999, through Dec. 31, 2007.
The primary outcome measure was SGA. Researchers registered demographic and obstetric characteristics including maternal age, parity, ethnicity, and socioeconomic status (SES).
Cases were analyzed in total and stratified into two groups: women with and without a hypertensive disorder in their first pregnancy. The analysis was stratified by gestational age at delivery in the first pregnancy in 3 groups: very preterm, late preterm, and full-term.
After exclusions, the study population was comprised of 259,481 women (518,962 deliveries). Five percent (12,943) of the women gave birth to SGA infants in their first pregnancy, and of those same women, SGA recurred in 2996 women (23.2 percent) in the subsequent pregnancy. SGA in the second pregnancy in women who had not previously had an SGA baby occurred in 3.4 percent of the women.
Further, the risk of SGA recurrence in women with hypertensive disorder in their first pregnancy was smaller than in women who did not. However, the risk of “de novo” SGA in the second pregnancy was higher for those with hypertensive disorder than their counterparts.
Abstract 86: SGA recurrence: analysis of first and subsequent singleton pregnancies in the Netherlands, 1999-2007.
Objective: Patterns of recurrence of restricted fetal growth are important for patient counseling and adequate care in subsequent pregnancies. Our objective was to study the recurrence rate of small for gestational age (SGA) neonates.
Study Design: We performed a prospective national cohort study using the Netherlands Perinatal Registry. The study population comprised all women with a first and subsequent pregnancy between 24 + 0 and 42 + 6 weeks gestation between 1999 and 2007. Multiple gestations and fetuses with structural or chromosomal abnormalities were excluded. SGA was defined as birth weight below the 5th percentile. The Dutch reference curves for birth weight by gestational age separate for parity, sex and ethnic background were used. Cases were categorized by gestational age at delivery in the first pregnancy; very preterm (24 + 0-31 + 6wks), preterm (32 + 0-36 + 6wks) and term (37 + 0-42 + 6wks). We compared the recurrence rate of SGA in the second pregnancy in women with and without SGA in their first pregnancy. Moreover, we assessed the incidence and recurrence rate of SGA in women with and without a hypertensive disorder (HTD) in their first pregnancy.
Results: We studied 259,481 pregnant women, of which 12.943 (5.0%) had an SGA baby in their first pregnancy. The overall risk of SGA recurrence was 23% , the risk of de novo SGA in the second pregnancy was 3.4% (Odds Ratio (OR) 8.5, 95% Confidence interval (CI) 8.1-8.9). The risk of SGA recurrence in HTD women was smaller than in non-HTD women (21.0% vs 23.7%, OR 0.86, 95% CI 0.77- 0.95). However, the risk of de novo SGA in the second pregnancy was higher for HTD women than for non-HTD women (4.1% vs. 3.4% OR 1.2 95% CI 1.2-1.3).
Conclusion: Women with SGA in their first pregnancy have a strongly increased risk for SGA in subsequent pregnancies. The SGA recurrence rate is smaller for women with a HTD in their first pregnancy than for women without a HTD. The risk on de novo SGA in the second pregnancy however, is higher in the HTD group than in the non-HTD group.
Abstract: Bart Jan Voskamp (1), Brenda Kazemier (1), Ben Willem Mol (1), Eva Pajkrt (1)
1: Academic Medical Center, Obstrics and Gynecology, Amsterdam, Netherlands
The Society for Maternal-Fetal Medicine (est. 1977) is a non-profit membership group for obstetricians/gynecologists who have additional formal education and training in maternal-fetal medicine. The society is devoted to reducing high-risk pregnancy complications by providing continuing education to its 2,000 members on the latest pregnancy assessment and treatment methods. It also serves as an advocate for improving public policy, and expanding research funding and opportunities for maternal-fetal medicine. The group hosts an annual scientific meeting in which new ideas and research in the area of maternal-fetal medicine are unveiled and discussed.
Society for Maternal-Fetal Medicine